Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Karam Elsolh"'
Autor:
Elaine McWhirter, Carly C Barron, Isabella Stefanova, Yevin Cha, Karam Elsolh, Arman Zereshkian, Nessma Gaafour
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss 8 (2023)
Immune-related adverse events (irAEs) are toxicities resulting from use of immune checkpoint inhibitors (ICIs). These side effects persist in some patients despite withholding therapy and using immunosuppressive and immune-modulating agents. Little i
Externí odkaz:
https://doaj.org/article/adc1efacb7cc4521912cffa0aa1f3182
Publikováno v:
PLoS ONE, Vol 16, Iss 5, p e0252155 (2021)
IntroductionThe United States Food and Drug Administration (FDA) Gastrointestinal Drug Advisory Committee (GIDAC) is involved in gastrointestinal drug application reviews. Characteristics and conflicts of interest (COI) in GIDAC meetings are not well
Externí odkaz:
https://doaj.org/article/f4fba966226b48adb7a4e44f6e42689c
Autor:
Michael A Scaffidi, Karam Elsolh, Juana Li, Yash Verma, Rishi Bansal, Nikko Gimpaya, Vincent Larivière, Rishad Khan, Samir C Grover
Publikováno v:
PLoS ONE, Vol 16, Iss 8, p e0256577 (2021)
BackgroundSince 2008, the Canadian Institutes of Health Research (CIHR) has mandated that studies it funds either in whole or in part are required to publish their results as open access (OA) within 12 months of publication using either online reposi
Externí odkaz:
https://doaj.org/article/4f896c8d4e734235b8c4d2420475799d
Autor:
Karam Elsolh, Daniel Tham, Michael A Scaffidi, Nikko Gimpaya, Rishi Bansal, Nazi Torabi, Juana Li, Yash Verma, Rishad Khan, Samir C Grover
Publikováno v:
Journal of the Canadian Association of Gastroenterology. 5:214-220
Background Propensity score matching (PSM), a statistical technique that estimates a treatment effect by accounting for predictor covariates, has been used to evaluate biologics for inflammatory bowel disease (IBD). Financial conflicts of interest ar
Autor:
Yash Verma, A Panjwani, Rishad Khan, Juana Li, Rishi Bansal, Michael A. Scaffidi, Nikko Gimpaya, Karam Elsolh, Samir C. Grover
Publikováno v:
Journal of the Canadian Association of Gastroenterology. 4:32-34
Background Editorial self-publication refers to the practice wherein editors publish research in journals to which they serve as editorial board members. The International Committee of Medical Journal Editors (ICMJE) has detailed recommendations agai
Autor:
Rishi Bansal, Yash Verma, Nikko Gimpaya, Karam Elsolh, Samir C. Grover, Juana Li, Michael A. Scaffidi, Rishad Khan, Abhishek Panjwani, Gemma M Donn
Publikováno v:
CMAJ Open
BACKGROUND: The quality of case reports, which are often the first reported evidence for a disease, may be negatively affected by a rush to publication early in a pandemic. We aimed to determine the completeness of reporting (COR) for case reports pu
Autor:
Nikko Gimpaya, Karam Elsolh, Samir C. Grover, Juana Li, Yash Verma, Michael A. Scaffidi, Rishi Bansal, Rishad Khan, Daniel Tham
Publikováno v:
J Can Assoc Gastroenterol
Background Inflammatory Bowel Disease (IBD) studies have commonly relied on real-world evidence to evaluate different therapies. An emerging idea has been the use of propensity score matching as a statistical method to account for baseline characteri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::52b305741ee88e7446d464c3e020c056
https://europepmc.org/articles/PMC7958738/
https://europepmc.org/articles/PMC7958738/
Autor:
Nikko Gimpaya, Yash Verma, Vincent Larivière, Karam Elsolh, Samir C. Grover, Rishad Khan, Rishi Bansal, Juana Li, Michael A. Scaffidi
Publikováno v:
PLoS ONE, Vol 16, Iss 8, p e0256577 (2021)
PLoS ONE
PLoS ONE
Background Since 2008, the Canadian Institutes of Health Research (CIHR) has mandated that studies it funds either in whole or in part are required to publish their results as open access (OA) within 12 months of publication using either online repos
Publikováno v:
PLoS ONE
PLoS ONE, Vol 16, Iss 5, p e0252155 (2021)
PLoS ONE, Vol 16, Iss 5, p e0252155 (2021)
Introduction The United States Food and Drug Administration (FDA) Gastrointestinal Drug Advisory Committee (GIDAC) is involved in gastrointestinal drug application reviews. Characteristics and conflicts of interest (COI) in GIDAC meetings are not wel
Autor:
Nikko Gimpaya, Juana Li, Karam Elsolh, Samir C. Grover, Rishad Khan, Rishi Bansal, Yash Verma, Michael A. Scaffidi
Publikováno v:
J Can Assoc Gastroenterol
Background Outcome switching is a well-described form of inconsistent reporting in randomized clinical trials (RCTs), wherein pre-specified primary and/or secondary outcomes are changed between trial registration and the publication of results withou